Safety Advisory Notice: Classification of MPXV Diagnostic Samples and Waste
The Safety Advisory Notice shares new advice from the Centers for Disease Control and Prevention (CDC) regarding diagnostic samples and clinical waste containing Monkeypox virus (MPXV) in Clade I or II. The advice clarifies that samples and clinical waste should be designated as Category B infectious substances except when they contain or are contaminated with cultures of Clade I MPXV.